Ownership

Christopher Durant Turner

Insider Reports History

Entity: Individual
Location: One Broadway, 14 Th Floor, Cambridge, MA
Signature: /s/ Nathan McConarty, attorney-in-fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Durant Turner:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Nuvalent, Inc.	Chief Medical Officer	Class A Common Stock	62.5K	$5.04M	$80.54	Jan 6, 2025	Direct
Nuvalent, Inc.	Chief Medical Officer	Stock Option (Right to Buy)	37.5K			Jan 6, 2025	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by Christopher Durant Turner

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
NUVL	Nuvalent, Inc.	Jan 6, 2025	5	-$320K	4	Jan 8, 2025	Chief Medical Officer
NUVL	Nuvalent, Inc.	Jan 5, 2024	2	$0	4	Jan 9, 2024	Chief Medical Officer
NUVL	Nuvalent, Inc.	Oct 4, 2023	8	-$377K	4	Oct 6, 2023	Chief Medical Officer
NUVL	Nuvalent, Inc.	Jul 26, 2023	6	-$207K	4	Jul 28, 2023	Chief Medical Officer
NUVL	Nuvalent, Inc.	Jul 20, 2023	6	-$12K	4	Jul 24, 2023	Chief Medical Officer
NUVL	Nuvalent, Inc.	Jun 5, 2023	3	-$389K	4	Jun 7, 2023	Chief Medical Officer
NUVL	Nuvalent, Inc.	Jan 6, 2023	1	$0	4	Jan 6, 2023	Chief Medical Officer
NUVL	Nuvalent, Inc.	May 17, 2022	2	$100K	4	May 19, 2022	Chief Medical Officer
NUVL	Nuvalent, Inc.	Jan 4, 2022	1	$0	4	Jan 5, 2022	Chief Medical Officer
NUVL	Nuvalent, Inc.	Jul 28, 2021	0	$0	3	Jul 28, 2021	Chief Medical Officer